-
FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE -
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
Amgen Signs with IBM
Discussion in 'Amgen IT' started by Anonymous, Oct 23, 2008 at 1:07 AM.
Tags:
Add Tags
Page 1 of 2
Page 1 of 2